We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current PRME market cap is 381.66M. The company's latest EPS is USD -1.5106 and P/E is -1.92.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Revenue | 0 | 0 | 591k | 0 | 209k |
| Operating Income | -51.46M | -68.04M | -48.34M | -55.67M | -54.23M |
| Net Income | -50.71M | -65.64M | -45.76M | -55.33M | -52.52M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 5.21M | 0 | 0 | 0 |
| Operating Income | -932k | -84.47M | -116.54M | -204.79M |
| Net Income | -5.06M | -184.12M | -142.01M | -198.13M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Assets | 239.15M | 193.85M | 311.38M | 259.71M | 332.78M |
| Total Liabilities | 45.19M | 60.78M | 67.62M | 63.12M | 143.28M |
| Total Equity | 193.96M | 133.07M | 243.77M | 196.59M | 189.5M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 54.78M | 301.86M | 360.31M | 193.85M |
| Total Liabilities | 21.31M | 62.3M | 44.04M | 60.78M |
| Total Equity | 2.34M | -156.24M | 316.27M | 133.07M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Operating | -121.55M | -165.41M | -67.71M | -113.2M | -139.11M |
| Investing | -22.57M | 18.71M | -37.03M | -30.14M | 20.2M |
| Financing | 461k | 655k | 157.33M | 157.36M | 195.88M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -5.54M | -34.08M | -131.83M | -165.41M |
| Investing | -1.06M | -73.63M | -47.1M | 18.71M |
| Financing | 34.93M | 269.28M | 181.49M | 655k |
| Market Cap | 381.66M |
| Price to Earnings Ratio | -1.92 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 9.15 |
| Price to Book Ratio | 2.86 |
| Dividend Yield | - |
| Shares Outstanding | 131.16M |
| Average Volume (1 week) | 1.2M |
| Average Volume (1 Month) | 1.24M |
| 52 Week Change | -69.30% |
| 52 Week High | 9.80 |
| 52 Week Low | 2.56 |
| Spread (Intraday) | 0.11 (3.78%) |
| Company Name | Prime Medicine Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.primemedicine.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
